What is the pregnancy category of rosuvastatin?

The correct pregnancy category of rosuvastatin is Category X. This classification indicates that studies in animals or humans have demonstrated fetal abnormalities, or there is clear evidence of risk to the human fetus based on human experience. The use of rosuvastatin during pregnancy is contraindicated because it poses a significant risk of harm to the developing fetus. This is particularly important for healthcare providers to consider when prescribing medications for women of childbearing age.

The other categories describe varying levels of risk during pregnancy, with Category A indicating no risk, Category B suggesting no evidence of risk in humans (but studies in animals may suggest otherwise), and Category C indicating that risk cannot be ruled out. Each category reflects a different level of safety based on available data regarding the drug and its impact on pregnancy, which reinforces the significance of the categorization assigned to rosuvastatin being Category X.